August 4, 2026 · Circulation · DOI: 10.1161/CIRCULATIONAHA.125.077971

Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury

Listen to this summary

The authors investigate the role of LAPTM4A, a lysosome-localized protein, in protecting against myocardial ischemia-reperfusion (MIR) injury, a condition that complicates heart revascularization. Their findings reveal that LAPTM4A enhances autophagic flux by interacting with Rubicon, thereby reducing inflammation and cell death during reperfusion. This suggests that targeting LAPTM4A could be a novel therapeutic strategy to mitigate MIR injury.

Siyi Zhou, Jiayi Liu, Manli Hu, Song Tian, Junjie Zhou, Wei Li, Hailian Chen, Maoji Yin, Shiyi Wang, Lei Luo, Long Zhang, Xiangqiang Zhou, Xu Cheng, Quanqing Qiu, Jinsheng Wang, Weiyi Qu, Yufeng Hu, Péter Ferdinandy, Mario Chiong, Mayarling F Troncoso, Zhaoliang Shan, Lan Bai, Hailong Yang, Hui Liu, Juan Wan, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Xin Zhang, Hongliang Li

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play